Travere Therapeutics Stock Forecast

Stock Price Forecast

According to 15 analysts polled by S&P Global, Travere Therapeutics stock has a consensus rating of "Strong Buy" and an average price target of $53.57. The average 1-year stock price forecast is 24.90% higher than the current stock price, while the lowest is $43 (+0.26%) and the highest is $60 (+39.89%).

Price Target: $53.57 (+24.90%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$43	$53.57	$54.5	$60
Change	+0.26%	+24.90%	+27.07%	+39.89%

Analyst Ratings

The average analyst rating for Travere Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Dec '25	Jan '26	Feb '26	Mar '26	Apr '26	May '26
Strong Buy	7	7	7	7	7	7
Buy	6	6	6	5	4	4
Hold	2	2	2	2	2	2
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	15	15	15	14	13	13

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Mohit Bansal Wells Fargo	Wells Fargo	Buy Maintains $40 → $50	Buy	Maintains	$40 → $50	+16.58%	May 6, 2026
Tyler Van Buren TD Cowen	TD Cowen	Strong Buy Maintains $45 → $60	Strong Buy	Maintains	$45 → $60	+39.89%	May 5, 2026
Yigal Nochomovitz Citigroup	Citigroup	Strong Buy Maintains $53 → $59	Strong Buy	Maintains	$53 → $59	+37.56%	May 5, 2026
Laura Chico Wedbush	Wedbush	Buy Maintains $53 → $55	Buy	Maintains	$53 → $55	+28.24%	May 5, 2026
Joseph Pantginis HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Maintains $47 → $57	Strong Buy	Maintains	$47 → $57	+32.90%	May 5, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

710.91M

from 490.73M

44.87%

from 490.73M

Revenue Next Year

978.54M

from 710.91M

37.65%

from 710.91M

EPS This Year

0.11

from -0.29

EPS Next Year

1.66

from 0.11

1,383.64%

from 0.11

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	131.84M	109.46M	145.24M	233.18M	490.73M	710.91M	978.54M
Revenue Growth	-33.52%	-16.97%	32.69%	60.55%	110.46%	44.87%	37.65%
EPS	-3.01	-4.37	-1.50	-4.08	-0.29	0.11	1.66
EPS Growth	-	-	-	-	-	-	1,383.64%
Forward PE	-	-	-	-	-	382.26	25.77
No. Analysts	-	-	-	-	-	17	17

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027
High	976.9M	1.4B
Avg	710.9M	978.5M
Low	583.1M	715.4M

Revenue Growth

Revenue Growth	2026	2027
High	99.1%	95.4%
Avg	44.9%	37.6%
Low	18.8%	0.6%

EPS Forecast

EPS	2026	2027
High	2.35	5.69
Avg	0.11	1.66
Low	-1.55	-0.35

EPS Growth

EPS Growth	2026	2027
High	-	4,972.2%
Avg	-	1,383.6%
Low	-	-

Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.